Abstract:Neuroinflammation following spinal cord injury usually aggravates spinal cord damage. Many inflammatory cytokines are key players in neuroinflammation. Owing largely to the multiplicity of cytokine targets and the complexity of cytokine interactions, it is insufficient to suppress spinal cord damage progression by regulating only one or a few cytokines. Herein, we propose a two-pronged strategy to simultaneously capture the released cytokines and inhibit the synthesis of new ones in a broad-spectrum manner. To achieve this strategy, we designed a core/shell-structured microcomposite, which was composed of a methylprednisolone-incorporated polymer inner core and a biocompatible polydopamine outer shell. Thanks to the inherent adhesive nature of polydopamine, the obtained microcomposite () efficiently neutralized the excessive cytokines in a broad-spectrum manner within 1 day after spinal cord injury. Meanwhile, the controlled release of immunosuppressive methylprednisolone reduced the secretion of new inflammatory cytokines. Benefiting from its efficient and broad-spectrum capability in reducing the level of cytokines, this core/shell-structured microcomposite suppressed the recruitment of macrophages and protected the injured spinal cord, leading to an improved recovery of motor function. Overall, the designed microcomposite successfully achieved the two-pronged strategy in cytokine neutralization, providing an alternative approach to inhibit neuroinflammation in the injured spinal cord.The Supporting Information is available free of charge at https://pubs.acs.org/doi/10.1021/acsami.1c11772.Size distribution and stability of MP nanoparticles in dimethyl carbonate; mass ratio of MP and PDA in with varied decoration time; the isotherm linear plots and BET plots of ; cell viabilities of primary neurons incubated with varying concentrations of for 72 h; the effect of on the level of IL-6, TNF-α, and IL-10 under the lipopolysaccharide (LPS) stimulation on glial cells; NF200-positive cells in the distant (>10 mm) field to the lesions plotted from VTEA analysis; and the myelin tissue around neuronal axons in the injury site by immunostaining the myelin basic protein (MBP) (PDF)This article has not yet been cited by other publications.

Citicoline–liposome/polyurethane composite scaffolds regulate the inflammatory response of microglia to promote nerve regeneration

Novel multi-drug delivery hydrogel using scar-homing liposomes improves spinal cord injury repair.

Targeting connexin 43 expression via scaffold mediated delivery of antisense oligodeoxynucleotide preserves neurons, enhances axonal extension, reduces astrocyte and microglial activation after spinal cord injury

Polydopamine-Decorated Microcomposites Promote Functional Recovery of an Injured Spinal Cord by Inhibiting Neuroinflammation

A novel hydrogel-based combination therapy for effective neuroregeneration after spinal cord injury

Advanced Therapies for Traumatic Central Nervous System Injury: Delivery Strategy Reinforced Efficient Microglial Manipulation

Effective Modulation of CNS Inhibitory Microenvironment using Bioinspired Hybrid-Nanoscaffold-Based Therapeutic Interventions

Novel nanocomposites improve functional recovery of spinal cord injury by regulating NF-κB mediated microglia polarization

Biomimetic nanoplatform with anti-inflammation and neuroprotective effects for repairing spinal cord injury in mice

LDH-doped gelatin-chitosan scaffold with aligned microchannels improves anti-inflammation and neuronal regeneration with guided axonal growth for effectively recovering spinal cord injury

Curcumin-Containing Polyphosphazene Nanodrug for Anti-Inflammation and Nerve Regeneration to Improve Functional Recovery After Spinal Cord Injury

Architecture‐engineered electrospinning cascade regulates spinal microenvironment to promote nerve regeneration

Ligand‐Screened Cerium‐Based MOF Microcapsules Promote Nerve Regeneration via Mitochondrial Energy Supply

Double crosslinked biomimetic composite hydrogels containing topographical cues and WAY-316606 induce neural tissue regeneration and functional recovery after spinal cord injury

Glycosaminoglycan scaffolding and neural progenitor cell transplantation promotes regenerative immunomodulation in the mouse ischemic brain

Correction to “Polysialic-Acid-based Micelles Promote Neural Regeneration in Spinal Cord Injury Therapy”

Neuroimmune modulating and energy supporting nanozyme-mimic scaffold synergistically promotes axon regeneration after spinal cord injury

Implantation of biomimetic polydopamine nanocomposite scaffold promotes optic nerve regeneration through modulating inhibitory microenvironment

Fibrous polypeptide based bioscaffold delivery of minocycline hydrochloride for nerve regeneration

Greatly improved neuroprotective efficiency of citicoline by stereotactic delivery in treatment of ischemic injury.

Nanoparticles loaded with a CSF1R antagonist selectively depletes microglial cells and modulates inflammation in spinal cord injury